We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
-0.12%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$3.91B
AUM Growth
+$545M
Cap. Flow
+$210M
Cap. Flow %
5.36%
Top 10 Hldgs %
40.38%
Holding
2,228
New
603
Increased
482
Reduced
356
Closed
557

Top Buys

Rank Stock Value
1
VOO icon
Vanguard S&P 500 ETF
VOO
+$84.4M
2
IWM icon
iShares Russell 2000 ETF
IWM
+$81.5M
3
VAL icon
Valaris
VAL
+$24.1M
4
CAI
CAI International, Inc.
CAI
+$12.6M
5
STMP
Stamps.com, Inc.
STMP
+$11M

Top Sells

Rank Stock Value
1
ALXN
Alexion Pharmaceuticals
ALXN
+$22.9M
2
PRAH
PRA Health Sciences, Inc.
PRAH
+$19.4M
3
PFPT
Proofpoint, Inc.
PFPT
+$19M
4
AAWW
Atlas Air Worldwide Holdings, Inc.
AAWW
+$16.1M
5
MXIM
Maxim Integrated Products
MXIM
+$15.5M

Sector Composition

Rank Sector Weight
1 Financials 9.4%
2 Technology 6.32%
3 Consumer Discretionary 5.14%
4 Industrials 4.27%
5 Communication Services 2.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EEM icon
1101
PUT
iShares MSCI Emerging Markets ETF
EEM
$29.8B
$307K 0.01%
6,100
+1,000
+20% +$52.1K
DBB icon
1102
Invesco DB Base Metals Fund
DBB
$318M
$306K 0.01%
+14,800
New +$304K
TLRY icon
1103
CALL
Tilray
TLRY
$602M
$305K 0.01%
2,700
-280
-9% -$38.4K
RBNC
1104
DELISTED
Reliant Bancorp, Inc. Common Stock
RBNC
$305K 0.01%
+9,662
New +$275K
CB icon
1105
Chubb
CB
$134B
$303K 0.01%
1,746
-9,956
-85% -$1.75M
DNLI icon
1106
Denali Therapeutics
DNLI
$4B
$303K 0.01%
6,012
+1,029
+21% +$58K
SCOB
1107
DELISTED
ScION Tech Growth II Class A Ordinary Shares
SCOB
$303K 0.01%
+30,671
New +$298K
GRMN
1108
Garmin
GRMN
$60.4B
$302K 0.01%
+1,941
New +$316K
U icon
1109
Unity
U
$19B
$300K 0.01%
+2,378
New +$282K
DELL icon
1110
Dell
DELL
$296B
$297K 0.01%
+5,627
New +$281K
APACU
1111
DELISTED
StoneBridge Acquisition Corporation Unit
APACU
$297K 0.01%
+29,480
New +$295K
NTRS icon
1112
Northern Trust
NTRS
$34.4B
$295K 0.01%
2,733
-305
-10% -$34.6K
BIIB icon
1113
Biogen
BIIB
$30.6B
$294K 0.01%
1,040
-4,957
-83% -$1.62M
SMTC icon
1114
Semtech
SMTC
$12.2B
$294K 0.01%
+3,772
New +$258K
SLV icon
1115
PUT
iShares Silver Trust
SLV
$32B
$293K 0.01%
14,300
-21,800
-60% -$490K
SU icon
1116
Suncor Energy
SU
$73.4B
$293K 0.01%
14,146
-114
-0.8% -$2.28K
XLRN
1117
CALL
DELISTED
Acceleron Pharma
XLRN
$293K 0.01%
+1,700
New +$222K
IBM icon
1118
PUT
IBM
IBM
$223B
$292K 0.01%
2,197
– –
CMCSA icon
1119
CALL
Comcast
CMCSA
$89.4B
$291K 0.01%
5,200
– –
GEO icon
1120
The GEO Group
GEO
$4.04B
$291K 0.01%
+38,975
New +$286K
LUNG icon
1121
Pulmonx
LUNG
$97.9M
$291K 0.01%
8,095
+104
+1% +$4.09K
FZT
1122
DELISTED
FAST Acquisition Corp. II
FZT
$291K 0.01%
30,000
+10,000
+50% +$97.1K
FTEV.U
1123
DELISTED
FinTech Evolution Acquisition Group Units, each consisting of one Class A Ordinary Share, and one-third of one redeemable warrant
FTEV.U
$291K 0.01%
+29,454
New +$292K
OKLO
1124
Oklo
OKLO
$8.28B
$290K 0.01%
+29,480
New +$291K
KRNT icon
1125
PUT
Kornit Digital
KRNT
$778M
$289K 0.01%
+2,000
New +$264K
43 44
45
46 47

Similar funds

PFBT
Parkside Financial Bank & Trust Saint Louis, Missouri $1.31B AUM 19.14% 1-Year Est. Return
CCP
Clarkston Capital Partners Rochester, Michigan $1.31B AUM 3.79% 1-Year Est. Return
SP
Sherman Porfolios Coeur D'alene, Idaho $1.3B AUM 35.18% 1-Year Est. Return
HCS
Himension Capital (Singapore) Singapore $1.3B AUM 85.53% 1-Year Est. Return
SPC
Silver Point Capital Greenwich, Connecticut $1.3B AUM 18.3% 1-Year Est. Return
GPCM
Greenbrier Partners Capital Management Dallas, Texas $1.3B AUM 21.43% 1-Year Est. Return
MCM
Mainstay Capital Management Grand Blanc, Michigan $1.3B AUM 37.8% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Prelude Capital Management's Q3 2021 Portfolio in Review

As of Q3 2021, Prelude Capital Management held 2,228 positions worth $3.91B, up 16% from $3.36B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Prelude Capital Management deployed $210M of net new capital in Q3 2021, opening 603 new positions and adding to 482 existing holdings. Its largest new stake was Vanguard S&P 500 ETF: 208,151 shares worth $82.1M.

By sector, the portfolio is most concentrated in Financials at 9.4% of assets, up from 8.9% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Frontier Communications, an estimated $8.65M trimmed.

  • Prelude Capital Management's largest Q3 2021 buy was Vanguard S&P 500 ETF: 208,151 shares worth $82.1M.
  • Prelude Capital Management added most to Valaris in Q3 2021, an estimated $24.1M increase.
  • Prelude Capital Management's biggest Q3 2021 reduction was Frontier Communications, cutting an estimated $8.65M.
  • Prelude Capital Management fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $22.9M.
  • Prelude Capital Management's ten largest holdings make up 40% of its $3.91B portfolio in Q3 2021.
  • Prelude Capital Management opened 603 new positions and closed 557 in Q3 2021.
  • Prelude Capital Management's portfolio value rose 16% quarter-over-quarter to $3.91B.

Based on Prelude Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.